EPOPROSTENOL
DrugBank ID: db01240
DrugCentral: epoprostenol
Synonymous :(5z,13e)-(15s)-6,9alpha-epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate | (5z,9α,11α,13e,15s)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid | epoprostenol | pgi2 | pgx | prostacyclin | prostaglandin i2 | prostaglandin x | vasocyclin
Drug Sentece Context
Table 1. Analysis of context sentence of epoprostenol gene in 9 abstracts.
pmid | sentence |
---|---|
32324366 | Inhalational nitric oxide (iNO), inhalational epoprostenol and veno-venous extracorporeal membrane oxygenation (ECMO) are options in severe hypoxemia that is unresponsive to conventional mechanical ventilation. |
32852238 | Interruptions in continuous nebulized pulmonary vasodilators, such as epoprostenol, can potentially result in clinical deterioration in respiratory status. […] In this study, we describe a unique method of administering continuous epoprostenol nebulization and intermittent nebulized antibiotics, mucolytics, and bronchodilators, using Aerogen vibrating mesh nebulizers without interruptions in epoprostenol or opening the ventilator circuit. |
32984987 | Our study revealed that only cilostazol has the most favorable binding interaction on Mpro (PDB ID: 6LU7) and cilostazol, iloprost, epoprostenol, prasugrel, and icosapent ethyl have a higher binding affinity on spike glycoprotein (S) (PDB ID: 6VYB) compared with recent anti-CoVID-19. |
33134949 | The objectives of this study were to evaluate the efficacy and safety of inhaled epoprostenol and inhaled nitric oxide in patients with refractory hypoxemia secondary to coronavirus disease 2019. […] Thirty-eight adult critically ill patients with coronavirus disease 2019 and refractory hypoxemia treated with either inhaled epoprostenol or inhaled nitric oxide for at least 1 hour between March 1, 2020, and June 30, 2020. […] Minimal adverse events were seen in patients who received either inhaled epoprostenol or inhaled nitric oxide. […] We found that the initiation of inhaled epoprostenol and inhaled nitric oxide in patients with refractory hypoxemia secondary to coronavirus disease 2019, on average, did not produce significant increases in oxygenation metrics. […] However, a group of patients had significant improvement with inhaled epoprostenol and inhaled nitric oxide. […] Administration of inhaled epoprostenol or inhaled nitric oxide may be considered in patients with severe respiratory failure secondary to coronavirus disease 2019. |
33354678 | To evaluate the effects of inhaled epoprostenol and prone positioning, individually and in combination in mechanically ventilated patients with coronavirus disease 2019 and refractory hypoxemia. […] Inhaled epoprostenol and prone positioning. […] In critically ill, mechanically ventilated patients with coronavirus disease 2019 who had refractory hypoxemia, oxygenation improved to a greater extent with combined use of inhaled epoprostenol and prone positioning than with each treatment individually. […] A higher proportion of responders to combined inhaled epoprostenol and prone positioning survived compared with nonresponders. |